Jiangfeng Wu

1.2k total citations
44 papers, 929 citations indexed

About

Jiangfeng Wu is a scholar working on Molecular Biology, Surgery and Hepatology. According to data from OpenAlex, Jiangfeng Wu has authored 44 papers receiving a total of 929 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Surgery and 12 papers in Hepatology. Recurrent topics in Jiangfeng Wu's work include Liver physiology and pathology (12 papers), RNA Interference and Gene Delivery (9 papers) and Liver Disease Diagnosis and Treatment (5 papers). Jiangfeng Wu is often cited by papers focused on Liver physiology and pathology (12 papers), RNA Interference and Gene Delivery (9 papers) and Liver Disease Diagnosis and Treatment (5 papers). Jiangfeng Wu collaborates with scholars based in China, United States and Canada. Jiangfeng Wu's co-authors include L.R. Carley, Gary K. Fedder, Lin‐Yan Wan, Yanqiong Zhang, Wen‐Bing Ai, Chang-Bai Liu, Liang‐Yin Chu, Hu Wang, Xueping Jiang and Yubin Huang and has published in prestigious journals such as Journal of Controlled Release, Molecules and IEEE Journal of Solid-State Circuits.

In The Last Decade

Jiangfeng Wu

39 papers receiving 904 citations

Peers

Jiangfeng Wu
Michael A. Lutz United States
Hao He China
Jiangfeng Wu
Citations per year, relative to Jiangfeng Wu Jiangfeng Wu (= 1×) peers Alexandra Fuchs

Countries citing papers authored by Jiangfeng Wu

Since Specialization
Citations

This map shows the geographic impact of Jiangfeng Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiangfeng Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiangfeng Wu more than expected).

Fields of papers citing papers by Jiangfeng Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiangfeng Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiangfeng Wu. The network helps show where Jiangfeng Wu may publish in the future.

Co-authorship network of co-authors of Jiangfeng Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiangfeng Wu. A scholar is included among the top collaborators of Jiangfeng Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiangfeng Wu. Jiangfeng Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Xihong, et al.. (2025). Liposome stability: multifactorial regulation and optimization strategies in in vivo delivery. Journal of Liposome Research. 35(4). 607–618.
2.
Deng, Kuan, et al.. (2025). An Area-Efficient High-Precision Analog Front End for Battery Management System. IEEE Transactions on Circuits & Systems II Express Briefs. 72(5). 783–787.
3.
Wang, Jinping, et al.. (2025). Methodological advances in liposomal encapsulation efficiency determination: systematic review and analysis. Journal of drug targeting. 33(8). 1262–1271. 2 indexed citations
4.
Zhang, Liye, Xiaojie Luo, Siyuan Wu, et al.. (2025). Hepatic-stellate-cell-targeted delivery of PU.1 decoy ODN by Apt-Tan attenuates liver fibrosis in mice. Molecular Therapy — Nucleic Acids. 36(3). 102607–102607.
5.
Yang, Xue, Lu Huang, Siyuan Wu, et al.. (2024). Targeted APT8(16–34) obtained by cell-SELEX and its internalization with miR-23-5p into activated hepatic stellate cells. Hepatology International. 19(4). 944–958. 1 indexed citations
6.
Xu, Cheng, Yong Tan, Liye Zhang, et al.. (2024). The Application of Aptamer and Research Progress in Liver Disease. Molecular Biotechnology. 66(5). 1000–1018. 5 indexed citations
7.
Liu, Meng‐Yuan, Lu Huang, Jiangfeng Wu, et al.. (2022). Possible roles of Golgi protein-73 in liver diseases. Annals of Hepatology. 27(5). 100720–100720. 16 indexed citations
8.
Zhang, Liye, et al.. (2022). The roles of ETS transcription factors in liver fibrosis. Human Cell. 36(2). 528–539. 3 indexed citations
9.
Fang, Qingqing, et al.. (2022). Discussion on the interpretation of the results and selection of the effect model in a meta-analysis. Annals of Palliative Medicine. 11(3). 1153–1154. 3 indexed citations
10.
Hu, Peng, Jiaojiao Wang, Xiaohui Liu, et al.. (2021). Relationship between the structure and function of the transcriptional regulator E2A. PubMed. 28(1). 15–15. 8 indexed citations
11.
Yang, Xue, et al.. (2021). Interaction of non‑parenchymal hepatocytes in the process of hepatic fibrosis (Review). Molecular Medicine Reports. 23(5). 15 indexed citations
12.
Rao, Chun, et al.. (2019). Class�C1 decoy oligodeoxynucleotide inhibits profibrotic genes expression in rat hepatic stellate cells. Molecular Medicine Reports. 21(2). 667–674. 3 indexed citations
13.
Hu, Peng, et al.. (2018). The roles of lncRNA in hepatic fibrosis. Cell & Bioscience. 8(1). 63–63. 53 indexed citations
14.
Yuan, Kai, Wen‐Bing Ai, Lin‐Yan Wan, Xiao Tan, & Jiangfeng Wu. (2017). The miR-290-295 cluster as multi-faceted players in mouse embryonic stem cells. Cell & Bioscience. 7(1). 38–38. 30 indexed citations
15.
Jiang, Xueping, Wen‐Bing Ai, Lin‐Yan Wan, Yanqiong Zhang, & Jiangfeng Wu. (2017). The roles of microRNA families in hepatic fibrosis. Cell & Bioscience. 7(1). 34–34. 81 indexed citations
16.
Zhang, Yanqiong, Lin‐Yan Wan, Xiaomin He, et al.. (2017). Gremlin1 Accelerates Hepatic Stellate Cell Activation Through Upregulation of TGF-Beta Expression. DNA and Cell Biology. 36(7). 603–610. 9 indexed citations
17.
Wan, Lin‐Yan, et al.. (2016). Liganded Vitamin D Receptor Through Its Interacting Repressor Inhibits the Expression of Type I Collagen α1. DNA and Cell Biology. 35(9). 498–505. 8 indexed citations
18.
Wan, Lin‐Yan, et al.. (2015). ‘Smart’ nanoparticles as drug delivery systems for applications in tumor therapy. Expert Opinion on Drug Delivery. 12(12). 1943–1953. 39 indexed citations
19.
Wu, Jiangfeng. (2010). The detection of HPV16 L1 from cervical tissue specimen. 2 indexed citations
20.
Wang, Hu, et al.. (2009). Enhancement of TAT cell membrane penetration efficiency by dimethyl sulphoxide. Journal of Controlled Release. 143(1). 64–70. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026